针对癌症治疗的偏酶1 (MALT1) 向:更新了结构-活性关系 (SAR) 的进展和研究
Yinglong Li1, Yanyun Hong1, Jianye Zhang1
1Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, 605 Fenglin Road, Nanchang, Jiangxi, 330013, China.
粘膜相关淋巴组织淋巴瘤转位蛋白1 (MALT1) 对于NF-κB信号传递至关重要,并与ABC-DLBCL有关. 本综述详细介绍了MALT1抑制剂,包括共价,全,PROTAC和探针,强调了未来药物开发的机会.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 粘膜关联淋巴组织淋巴瘤转位蛋白1 (MALT1) 是一种对通过CBM复合体进行NF-κB信号传递至关重要的类比酶.
- MALT1的双蛋白酶和支架功能是该途径的关键调节者.
- 像扩散型大B细胞淋巴瘤 (ABC-DLBCL) 这样的激活B细胞的发病因子依赖NF-κB,使MALT1成为关键的治疗标.
研究的目的:
- 审查目前关于MALT1抑制剂的研究进展.
- 分析各种MALT1抑制剂类的结构-活性关系 (SARs).
- 讨论MALT1向药物开发的未来挑战和机遇.
主要方法:
- 关于MALT1抑制剂的文献综述.
- 结构-活动关系 (SARs) 的分析.
- 讨论共价抑制剂,全抑制剂,PROTACs和基于活动的探针.
主要成果:
- 概述MALT1抑制剂研究进展情况.
- 对不同类型的抑制剂进行详细的SAR分析.
- 确定关键研究领域和潜在的治疗策略.
结论:
- 由于其在NF-κB信号传递中的作用,MALT1是ABC-DLBCL的重要治疗点.
- 不同的抑制剂策略,包括共价,全,PROTACs和探针,显示出有希望.
- 对MALT1抑制剂的进一步研究对于开发ABC-DLBCL的有效治疗方法至关重要.
更多相关视频
05:56Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Caspases
